Inicio>>Signaling Pathways>> Tyrosine Kinase>> Spleen Tyrosine Kinase (Syk)>>Cevidoplenib dimesylate

Cevidoplenib dimesylate (Synonyms: SKI-O-703 dimesylate)

Catalog No.GC63455

Cevidoplenib es un inhibidor disponible por vÍa oral de la tirosina quinasa del bazo (Syk), con posibles actividades antiinflamatorias e inmunomoduladoras.

Products are for research use only. Not for human use. We do not sell to patients.

Cevidoplenib dimesylate Chemical Structure

Cas No.: 2043659-93-2

Tamaño Precio Disponibilidad Cantidad
10m (in 1mL DMSO)
293,00 $
Disponible
5mg
266,00 $
Disponible
10mg
420,00 $
Disponible
25mg
805,00 $
Disponible
50mg
1.260,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2].

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.
[2]. cevidoplenib dimesylate.

Reseñas

Review for Cevidoplenib dimesylate

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cevidoplenib dimesylate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.